Report
by
Health Canada Drug Analysis Service
Release Date
2023
Geography
Canada
Language of Resource
English and French
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
No
Findings/Key points
Since 2019, there has been an increase in the number of Xylazine identifications in samples submitted to the Drug Analysis Service (DAS) by Canadian law enforcement agencies. 93% of exhibits containing Xylazine were in powder form. In 2022, 75% of samples containing Xylazine were submitted by law enforcement agencies from Ontario. 79% of Xylazine samples contained 2 to 4 co-occurring substances. Fentanyl was the most frequent co-occurring psychoactive substance, occurring in 93% of samples.
Français : https://www.canada.ca/fr/sante-canada/services/publications/vie-saine/e…
Keywords
Drug checking
Legal system/law enforcement
Illegal drugs
